摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Amino-1-methylthiocarbamyl-1H-1,2,4-triazol | 89603-53-2

中文名称
——
中文别名
——
英文名称
3-Amino-1-methylthiocarbamyl-1H-1,2,4-triazol
英文别名
3-amino-[1,2,4]triazole-1-carbothioic acid methylamide;3-amino-N-methyl-1,2,4-triazole-1-carbothioamide
3-Amino-1-methylthiocarbamyl-1H-1,2,4-triazol化学式
CAS
89603-53-2
化学式
C4H7N5S
mdl
——
分子量
157.199
InChiKey
OJLLAPUQDDHCIY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    101
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    3-氨基-1,2,4-三氮唑异硫氰酸甲酯N,N-二甲基甲酰胺 为溶剂, 反应 60.0h, 以18%的产率得到5-amino-N-methyl-1H-1,2,4-triazole-1-carbothioamide
    参考文献:
    名称:
    Synthesis and Pharmacological Activity of Triazole Derivatives Inhibiting Eosinophilia
    摘要:
    In order to develop novel antiasthmatic agents based on a new mechanism of action, a series of 3-substituted 5-amino-1-[(methylamino)(thiocarbonyl)]-1H-1,2,4-triazole derivatives were synthesized and evaluated in a model in which eosinophilia was induced in the ah-way through intravenous (iv) injection of Sephadex particles on days 0, 2, and 5. After screening of several hundred derivatives, we finally identified the highly potent eosinophilia inhibitor 5-amino-3-(4-chlorophenyl)-1-[(methylamino)(thiocarbonyl)]-1H-triazole (23c, GCC-AP0341), which had ID50 values of 0.3 and 0.07 mg/kg when administered orally (os) and intraperitoneally tip), respectively. This compound showed complete inhibition of the hypersensitivity induced by ascaris inhalation at an ip dose of 1 mg/kg as well as low toxicity, with an LD(50) value of > 2.0 g/kg in mice. Extensive study of its mechanism of action revealed that 23c inhibited eosinophil survival induced by interleukin-5 (IL-5), but had little or no effect on leukotriene D-4 (LTD(4)) or platelet-activating factor (PAF)-induced responses. Taken together, these results suggest 23e as a novel candidate for the treatment of chronic asthma. Further studies are now underway.
    DOI:
    10.1021/jm9507993
点击查看最新优质反应信息